PHF6 mutation is associated with poor outcome in acute myeloid leukaemia.

Cancer Med · 2023 · PMC9939093 · PMID 36176187

Europe PMC DOI

hedged sentence

0.6640

closest p · 13.3× alpha

0.6640

boldest claim

The sentences

showed a trendp = 0.664not close (p > 0.1)

Our data showed a trend for a shorter RFS in PHF6 mut AML (8.0 vs. 19.0 months; p = 0.664), although there were no significant differences in RFS or remission duration, which was partly due to the relatively small sample size.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.